EATG is concerned by the Cochrane review of DAA treatment against HCV infection

21/06

Direct acting agents used against hepatitis C infection are clinically effective and reliable. EATG, the pan-European network of communities of…

EATG joins new coalition calling on EU to take action to eliminate viral hepatitis by 2030

09/06

Launched at an event in the European Parliament on 7 June 2017, the ACHIEVE (short for Associations Collaborating on Hepatitis…

EATG Tuberculosis Team met Belgian Senate

17/05

  On May 15, EATG and TBpeople, EECA network of people with tuberculosis with support from the Stop TB Partnership, convened a…

Fall in HIV among gay men could spell end for Britain’s epidemic, say experts

22/06

Public Health England records first downturn in infections in London, thanks to frequent testing and rapid treatment A big drop…

Vaccines can be deemed defective without scientific proof, EU court rules

22/06

The medical world has found no causal relationship between hepatitis B vaccines and nervous system diseases such as multiple sclerosis,…

How six NYC activists changed history with “Silence = Death”

22/06

The collective that created the Silence = Death poster is back after thirty years to recall its origins and launch…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

EATG is pleased to share this new resource: Access to highly effective hepatitis C treatment in Portugal - A Community…

The European AIDS Treatment News (EATN) complete collection 1992 – 2001 is now available

03/08

The EATG published the European AIDS Treatment News (EATN) for 10 years. This “newsletter” disseminated information for expert patients and treatment activists…

Beyond viral suppression of HIV – the new quality of life frontier

23/06

Co authored by Luís Mendão and Nikos Dedes, both members of the Board of Directors, this article in BMC Medicine discusses…

EATG is concerned by the Cochrane review of DAA treatment against HCV infection

21/06

Direct acting agents used against hepatitis C infection are clinically effective and reliable. EATG, the pan-European network of communities of…

EATG joins new coalition calling on EU to take action to eliminate viral hepatitis by 2030

09/06

Launched at an event in the European Parliament on 7 June 2017, the ACHIEVE (short for Associations Collaborating on Hepatitis…

EATG Tuberculosis Team met Belgian Senate

17/05

  On May 15, EATG and TBpeople, EECA network of people with tuberculosis with support from the Stop TB Partnership, convened a…

Fall in HIV among gay men could spell end for Britain’s epidemic, say experts

22/06

Public Health England records first downturn in infections in London, thanks to frequent testing and rapid treatment A big drop…

Vaccines can be deemed defective without scientific proof, EU court rules

22/06

The medical world has found no causal relationship between hepatitis B vaccines and nervous system diseases such as multiple sclerosis,…

How six NYC activists changed history with “Silence = Death”

22/06

The collective that created the Silence = Death poster is back after thirty years to recall its origins and launch…

Access to highly effective hepatitis C treatment in Portugal – A Community Perspective

16/12

EATG is pleased to share this new resource: Access to highly effective hepatitis C treatment in Portugal - A Community…

The European AIDS Treatment News (EATN) complete collection 1992 – 2001 is now available

03/08

The EATG published the European AIDS Treatment News (EATN) for 10 years. This “newsletter” disseminated information for expert patients and treatment activists…

Beyond viral suppression of HIV – the new quality of life frontier

23/06

Co authored by Luís Mendão and Nikos Dedes, both members of the Board of Directors, this article in BMC Medicine discusses…